- Home
- ZJYL vs NRSN Comparison
ZJYL vs NRSN Comparison
Compare ZJYL & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZJYL | NRSN |
|---|---|---|
| Founded | 2006 | 2017 |
| Country | China | Israel |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 26.4M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ZJYL | NRSN |
|---|---|---|
| Price | $0.26 | $0.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 151.6K | ★ 329.1K |
| Earning Date | 08-20-2025 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $22,826,624.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.07 | ★ N/A |
| Revenue Growth | ★ 13.42 | N/A |
| 52 Week Low | $0.18 | $0.68 |
| 52 Week High | $1.12 | $2.60 |
Technical Indicators
Market Signals| Indicator | ZJYL | NRSN |
|---|---|---|
| Relative Strength Index (RSI) | 61.42 | 53.86 |
| Support Level | $0.21 | $0.81 |
| Resistance Level | $0.25 | $0.90 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 89.89 | 100.00 |
Price Performance
Historical ComparisonAbout ZJYL JIN MEDICAL INTERNATIONAL LTD.
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.